Vault-13

Bellevue Group AG

ZURICH, V8 · CIK 1674546 · 13F filing filed 2025-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Other 13F filers in this group: Bellevue Asset Management AG files a notice

$4.5bn reported value +1.7% vs Q1 2025
142positions
49.8%in top 10
7 new 39 added 61 reduced 13 sold out vs Q1 2025

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARGENX SE SPONSORED ADR ARGX ARGX 571,039 $314.8m6.94% 6.94% ReducedShares held: Q3 2024 632.8k, Q4 2024 593.2k, Q1 2025 578.9k, Q2 2025 571.0k -7.8k -7,835 -1.4%
2 IONIS PHARMACEUTICALS INC COM IONS IONS 7,853,198 $310.3m6.84% 6.84% UnchangedShares held: Q3 2024 7.9m, Q4 2024 7.9m, Q1 2025 7.9m, Q2 2025 7.9m
3 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,820,000 $228.8m5.04% 5.04% UnchangedShares held: Q3 2024 1.9m, Q4 2024 1.8m, Q1 2025 1.8m, Q2 2025 1.8m
4 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 676,367 $220.6m4.86% 4.86% ReducedShares held: Q3 2024 809.1k, Q4 2024 770.3k, Q1 2025 768.1k, Q2 2025 676.4k -91.8k -91,780 -11.9%
5 ABBOTT LABS COM ABT ABT 1,564,022 $212.7m4.69% 4.69% AddedShares held: Q3 2024 1.7m, Q4 2024 1.7m, Q1 2025 1.6m, Q2 2025 1.6m +7.9k +7,893 0.5%
6 STRYKER CORPORATION COM SYK SYK 535,089 $211.7m4.67% 4.67% ReducedShares held: Q3 2024 526.6k, Q4 2024 520.0k, Q1 2025 566.6k, Q2 2025 535.1k -31.5k -31,508 -5.6%
7 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 378,728 $205.8m4.54% 4.54% ReducedShares held: Q3 2024 496.8k, Q4 2024 464.4k, Q1 2025 425.7k, Q2 2025 378.7k -47.0k -47,018 -11.0%
8 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 441,610 $196.6m4.33% 4.33% AddedShares held: Q3 2024 571.4k, Q4 2024 487.4k, Q1 2025 413.1k, Q2 2025 441.6k +28.5k +28,539 6.9%
9 BOSTON SCIENTIFIC CORP COM BSX BSX 1,765,194 $189.6m4.18% 4.18% ReducedShares held: Q3 2024 2.5m, Q4 2024 2.1m, Q1 2025 2.0m, Q2 2025 1.8m -185.8k -185,826 -9.5%
10 REVOLUTION MEDICINES INC COM RVMD RVMD 4,579,300 $168.5m3.71% 3.71% AddedShares held: Q3 2024 4.9m, Q4 2024 4.4m, Q1 2025 4.4m, Q2 2025 4.6m +205.0k +205,000 4.7%
11 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 3,590,150 $119.4m2.63% 2.63% AddedShares held: Q3 2024 3.7m, Q4 2024 3.5m, Q1 2025 3.5m, Q2 2025 3.6m +75.0k +75,000 2.1%
12 INCYTE CORP COM INCY INCY 1,570,333 $106.9m2.36% 2.36% ReducedShares held: Q3 2024 2.2m, Q4 2024 2.2m, Q1 2025 2.1m, Q2 2025 1.6m -521.4k -521,447 -24.9%
13 AKERO THERAPEUTICS INC COM AKRO AKRO 1,985,272 $105.9m2.33% 2.33% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 1.3m, Q2 2025 2.0m +734.6k +734,606 58.7%
14 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 2,947,295 $104.4m2.30% 2.30% AddedShares held: Q3 2024 2.2m, Q4 2024 2.5m, Q1 2025 2.5m, Q2 2025 2.9m +440.4k +440,405 17.6%
15 MEDTRONIC PLC SHS MDT MDT 921,043 $80.3m1.77% 1.77% ReducedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 938.4k, Q2 2025 921.0k -17.3k -17,312 -1.8%
16 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 2,441,830 $76.6m1.69% 1.69% AddedShares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.2m, Q2 2025 2.4m +1.2m +1,220,036 99.9%
17 DEXCOM INC COM DXCM DXCM 860,828 $75.1m1.66% 1.66% ReducedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.1m, Q2 2025 860.8k -203.3k -203,280 -19.1%
18 EDWARDS LIFESCIENCES CORP COM EW EW 889,077 $69.5m1.53% 1.53% ReducedShares held: Q3 2024 1.1m, Q4 2024 1.1m, Q1 2025 972.0k, Q2 2025 889.1k -82.9k -82,892 -8.5%
19 INSULET CORP COM PODD PODD 219,013 $68.8m1.52% 1.52% ReducedShares held: Q3 2024 421.5k, Q4 2024 321.9k, Q1 2025 271.3k, Q2 2025 219.0k -52.3k -52,273 -19.3%
20 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 3,307,569 $67.3m1.48% 1.48% AddedShares held: Q3 2024 3.1m, Q4 2024 3.1m, Q1 2025 3.1m, Q2 2025 3.3m +236.0k +235,954 7.7%
21 BECTON DICKINSON & CO COM BDX BDX 316,732 $54.6m1.20% 1.20% ReducedShares held: Q3 2024 337.6k, Q4 2024 337.5k, Q1 2025 344.3k, Q2 2025 316.7k -27.6k -27,579 -8.0%
22 BEAM THERAPEUTICS INC COM BEAM BEAM 2,889,288 $49.1m1.08% 1.08% AddedShares held: Q3 2024 1.5m, Q4 2024 1.5m, Q1 2025 2.4m, Q2 2025 2.9m +493.4k +493,358 20.6%
23 THERMO FISHER SCIENTIFIC INC COM TMO TMO 113,544 $46.0m1.01% 1.01% AddedShares held: Q3 2024 53.6k, Q4 2024 61.0k, Q1 2025 64.2k, Q2 2025 113.5k +49.3k +49,312 76.8%
24 PENUMBRA INC COM PEN PEN 174,050 $44.7m0.98% 0.98% ReducedShares held: Q3 2024 272.7k, Q4 2024 238.1k, Q1 2025 204.5k, Q2 2025 174.1k -30.5k -30,467 -14.9%
25 UNITEDHEALTH GROUP INC COM UNH UNH 142,296 $44.4m0.98% 0.98% ReducedShares held: Q3 2024 225.6k, Q4 2024 159.7k, Q1 2025 164.7k, Q2 2025 142.3k -22.4k -22,446 -13.6%
26 RESMED INC COM RMD RMD 165,802 $42.8m0.94% 0.94% UnchangedShares held: Q3 2024 160.1k, Q4 2024 160.8k, Q1 2025 165.8k, Q2 2025 165.8k
27 IDEXX LABS INC COM IDXX IDXX 76,548 $41.1m0.90% 0.90% ReducedShares held: Q3 2024 91.3k, Q4 2024 76.9k, Q1 2025 76.9k, Q2 2025 76.5k -349 -349 -0.5%
28 BIOHAVEN LTD COM BHVN BHVN 2,802,853 $39.5m0.87% 0.87% AddedShares held: Q3 2024 2.0m, Q4 2024 2.0m, Q1 2025 2.0m, Q2 2025 2.8m +762.0k +762,000 37.3%
29 GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC GEHC 515,468 $38.2m0.84% 0.84% ReducedShares held: Q3 2024 532.0k, Q4 2024 524.4k, Q1 2025 524.4k, Q2 2025 515.5k -8.9k -8,946 -1.7%
30 HCA HEALTHCARE INC COM HCA HCA 99,122 $38.0m0.84% 0.84% AddedShares held: Q3 2024 114.5k, Q4 2024 61.9k, Q1 2025 61.8k, Q2 2025 99.1k +37.3k +37,315 60.4%
31 THE CIGNA GROUP COM CI CI 110,712 $36.6m0.81% 0.81% ReducedShares held: Q3 2024 118.4k, Q4 2024 125.2k, Q1 2025 117.5k, Q2 2025 110.7k -6.8k -6,823 -5.8%
32 BLUEPRINT MEDICINES CORP COM BPMC BPMC 284,900 $36.5m0.80% 0.80% NewShares held: Q3 2024 3.2k, Q4 2024 3.2k, Q1 2025 0, Q2 2025 284.9k
33 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 2,775,997 $36.4m0.80% 0.80% AddedShares held: Q3 2024 1.4m, Q4 2024 1.4m, Q1 2025 1.4m, Q2 2025 2.8m +1.3m +1,347,068 94.3%
34 MODERNA INC COM MRNA MRNA 1,238,668 $34.2m0.75% 0.75% ReducedShares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.5m, Q2 2025 1.2m -279.5k -279,454 -18.4%
35 VEEVA SYS INC CL A COM VEEV VEEV 113,333 $32.6m0.72% 0.72% AddedShares held: Q3 2024 163.5k, Q4 2024 127.6k, Q1 2025 113.2k, Q2 2025 113.3k +83 +83 0.1%
36 ELEVANCE HEALTH INC COM ELV ELV 82,053 $31.9m0.70% 0.70% AddedShares held: Q3 2024 89.3k, Q4 2024 38.3k, Q1 2025 40.1k, Q2 2025 82.1k +42.0k +41,995 104.8%
37 ELI LILLY & CO COM LLY LLY 40,920 $31.9m0.70% 0.70% ReducedShares held: Q3 2024 44.2k, Q4 2024 45.5k, Q1 2025 43.6k, Q2 2025 40.9k -2.7k -2,727 -6.2%
38 MCKESSON CORP COM MCK MCK 40,466 $29.7m0.65% 0.65% AddedShares held: Q3 2024 35.7k, Q4 2024 19.3k, Q1 2025 30.6k, Q2 2025 40.5k +9.9k +9,886 32.3%
39 ABBVIE INC COM ABBV ABBV 159,661 $29.6m0.65% 0.65% AddedShares held: Q3 2024 42.9k, Q4 2024 45.3k, Q1 2025 135.2k, Q2 2025 159.7k +24.4k +24,421 18.1%
40 ALIGN TECHNOLOGY INC COM ALGN ALGN 150,787 $28.5m0.63% 0.63% ReducedShares held: Q3 2024 144.0k, Q4 2024 160.0k, Q1 2025 151.0k, Q2 2025 150.8k -206 -206 -0.1%
41 RELAY THERAPEUTICS INC COM RLAY RLAY 8,230,870 $28.5m0.63% 0.63% AddedShares held: Q3 2024 7.4m, Q4 2024 7.4m, Q1 2025 7.4m, Q2 2025 8.2m +853.6k +853,578 11.6%
42 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 489,278 $28.2m0.62% 0.62% AddedShares held: Q3 2024 612.7k, Q4 2024 462.9k, Q1 2025 414.9k, Q2 2025 489.3k +74.4k +74,355 17.9%
43 DANAHER CORPORATION COM DHR DHR 136,811 $27.0m0.60% 0.60% AddedShares held: Q3 2024 105.6k, Q4 2024 119.9k, Q1 2025 124.3k, Q2 2025 136.8k +12.5k +12,490 10.1%
44 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,094,458 $26.6m0.59% 0.59% UnchangedShares held: Q3 2024 4.1m, Q4 2024 4.1m, Q1 2025 4.1m, Q2 2025 4.1m
45 STERIS PLC SHS USD STE STE 109,887 $26.4m0.58% 0.58% UnchangedShares held: Q3 2024 91.3k, Q4 2024 109.9k, Q1 2025 109.9k, Q2 2025 109.9k
46 COOPER COS INC COM COO COO 356,074 $25.3m0.56% 0.56% ReducedShares held: Q3 2024 397.4k, Q4 2024 357.1k, Q1 2025 357.0k, Q2 2025 356.1k -951 -951 -0.3%
47 NATERA INC COM NTRA NTRA 147,491 $24.9m0.55% 0.55% AddedShares held: Q3 2024 138.5k, Q4 2024 145.7k, Q1 2025 113.2k, Q2 2025 147.5k +34.3k +34,272 30.3%
48 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 267,716 $24.4m0.54% 0.54% ReducedShares held: Q3 2024 432.8k, Q4 2024 293.6k, Q1 2025 291.3k, Q2 2025 267.7k -23.6k -23,630 -8.1%
49 MOLINA HEALTHCARE INC COM MOH MOH 74,022 $22.1m0.49% 0.49% ReducedShares held: Q3 2024 67.6k, Q4 2024 82.2k, Q1 2025 75.9k, Q2 2025 74.0k -1.9k -1,873 -2.5%
50 GLOBUS MED INC CL A GMED GMED 332,336 $19.6m0.43% 0.43% UnchangedShares held: Q3 2024 469.8k, Q4 2024 363.0k, Q1 2025 332.3k, Q2 2025 332.3k
51 TRANSMEDICS GROUP INC COM TMDX TMDX 130,517 $17.5m0.39% 0.39% ReducedShares held: Q3 2024 169.8k, Q4 2024 192.7k, Q1 2025 173.7k, Q2 2025 130.5k -43.2k -43,193 -24.9%
52 ENCOMPASS HEALTH CORP COM EHC EHC 131,741 $16.2m0.36% 0.36% ReducedShares held: Q3 2024 19.2k, Q4 2024 188.5k, Q1 2025 172.9k, Q2 2025 131.7k -41.1k -41,137 -23.8%
53 HOLOGIC INC COM HOLX HOLX 247,886 $16.2m0.36% 0.36% UnchangedShares held: Q3 2024 247.9k, Q4 2024 247.9k, Q1 2025 247.9k, Q2 2025 247.9k
54 EXACT SCIENCES CORP COM EXAS EXAS 284,201 $15.1m0.33% 0.33% ReducedShares held: Q3 2024 1.4m, Q4 2024 694.1k, Q1 2025 579.1k, Q2 2025 284.2k -294.9k -294,873 -50.9%
55 MASIMO CORP COM MASI MASI 89,673 $15.1m0.33% 0.33% AddedShares held: Q3 2024 0, Q4 2024 24.2k, Q1 2025 69.8k, Q2 2025 89.7k +19.9k +19,865 28.5%
56 CAREDX INC COM CDNA CDNA 752,371 $14.7m0.32% 0.32% ReducedShares held: Q3 2024 3.1m, Q4 2024 1.4m, Q1 2025 889.0k, Q2 2025 752.4k -136.6k -136,632 -15.4%
57 PRIVIA HEALTH GROUP INC COM PRVA PRVA 630,697 $14.5m0.32% 0.32% ReducedShares held: Q3 2024 1.1m, Q4 2024 953.2k, Q1 2025 697.3k, Q2 2025 630.7k -66.6k -66,611 -9.6%
58 REGENERON PHARMACEUTICALS COM REGN REGN 26,744 $14.0m0.31% 0.31% ReducedShares held: Q3 2024 26.8k, Q4 2024 31.4k, Q1 2025 28.5k, Q2 2025 26.7k -1.8k -1,779 -6.2%
59 ANNEXON INC COM ANNX ANNX 5,157,290 $12.4m0.27% 0.27% UnchangedShares held: Q3 2024 5.2m, Q4 2024 5.2m, Q1 2025 5.2m, Q2 2025 5.2m
60 HUMANA INC COM HUM HUM 49,124 $12.0m0.26% 0.26% AddedShares held: Q3 2024 28.4k, Q4 2024 28.4k, Q1 2025 28.3k, Q2 2025 49.1k +20.8k +20,826 73.6%
61 MACROGENICS INC COM MGNX MGNX 9,919,992 $12.0m0.26% 0.26% ReducedShares held: Q3 2024 9.9m, Q4 2024 9.9m, Q1 2025 9.9m, Q2 2025 9.9m -10.0k -9,971 -0.1%
62 JOHNSON & JOHNSON COM JNJ JNJ 68,211 $10.4m0.23% 0.23% AddedShares held: Q3 2024 51.2k, Q4 2024 54.6k, Q1 2025 67.0k, Q2 2025 68.2k +1.2k +1,202 1.8%
63 SI-BONE INC COM SIBN SIBN 540,112 $10.2m0.22% 0.22% ReducedShares held: Q3 2024 1.4m, Q4 2024 881.0k, Q1 2025 873.0k, Q2 2025 540.1k -332.9k -332,879 -38.1%
64 INSPIRE MED SYS INC COM INSP INSP 75,660 $9.8m0.22% 0.22% ReducedShares held: Q3 2024 195.1k, Q4 2024 148.5k, Q1 2025 99.0k, Q2 2025 75.7k -23.4k -23,367 -23.6%
65 LABCORP HOLDINGS INC COM SHS LH LH 36,692 $9.6m0.21% 0.21% AddedShares held: Q3 2024 206, Q4 2024 216, Q1 2025 28.1k, Q2 2025 36.7k +8.6k +8,551 30.4%
66 PHREESIA INC COM PHR PHR 332,016 $9.4m0.21% 0.21% ReducedShares held: Q3 2024 422.4k, Q4 2024 405.7k, Q1 2025 376.2k, Q2 2025 332.0k -44.1k -44,147 -11.7%
67 BEIGENE LTD SPONSORED ADR ONC ONC 38,698 $9.4m0.21% 0.21% AddedShares held: Q3 2024 58.7k, Q4 2024 34.2k, Q1 2025 35.3k, Q2 2025 38.7k +3.4k +3,369 9.5%
68 QUEST DIAGNOSTICS INC COM DGX DGX 48,567 $8.7m0.19% 0.19% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 48.6k
69 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 151,445 $8.3m0.18% 0.18% ReducedShares held: Q3 2024 331.0k, Q4 2024 329.0k, Q1 2025 368.4k, Q2 2025 151.4k -216.9k -216,928 -58.9%
70 INSMED INC COM PAR $.01 INSM INSM 81,397 $8.2m0.18% 0.18% ReducedShares held: Q3 2024 525.4k, Q4 2024 258.5k, Q1 2025 150.6k, Q2 2025 81.4k -69.2k -69,153 -45.9%
71 CENTENE CORP DEL COM CNC CNC 139,310 $7.6m0.17% 0.17% AddedShares held: Q3 2024 86.7k, Q4 2024 86.5k, Q1 2025 86.2k, Q2 2025 139.3k +53.1k +53,092 61.6%
72 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 348,527 $7.2m0.16% 0.16% AddedShares held: Q3 2024 629.8k, Q4 2024 485.1k, Q1 2025 221.7k, Q2 2025 348.5k +126.8k +126,812 57.2%
73 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 421,501 $7.1m0.16% 0.16% AddedShares held: Q3 2024 70.8k, Q4 2024 60.6k, Q1 2025 28.9k, Q2 2025 421.5k +392.6k +392,571 1357.0%
74 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 2,733,547 $6.8m0.15% 0.15% UnchangedShares held: Q3 2024 8.5m, Q4 2024 8.5m, Q1 2025 2.7m, Q2 2025 2.7m
75 AMGEN INC COM AMGN AMGN 24,108 $6.7m0.15% 0.15% ReducedShares held: Q3 2024 25.2k, Q4 2024 89.2k, Q1 2025 80.9k, Q2 2025 24.1k -56.8k -56,827 -70.2%
76 NEOGENOMICS INC COM NEW NEO NEO 913,082 $6.7m0.15% 0.15% ReducedShares held: Q3 2024 1.6m, Q4 2024 1.1m, Q1 2025 1.2m, Q2 2025 913.1k -303.7k -303,674 -25.0%
77 WAYSTAR HLDG CORP COM WAY WAY 150,610 $6.2m0.14% 0.14% AddedShares held: Q3 2024 150.2k, Q4 2024 157.9k, Q1 2025 144.4k, Q2 2025 150.6k +6.2k +6,184 4.3%
78 AXSOME THERAPEUTICS INC COM AXSM AXSM 56,253 $5.9m0.13% 0.13% ReducedShares held: Q3 2024 367.2k, Q4 2024 118.9k, Q1 2025 96.4k, Q2 2025 56.3k -40.2k -40,154 -41.6%
79 GLAUKOS CORP COM GKOS GKOS 55,926 $5.8m0.13% 0.13% UnchangedShares held: Q3 2024 63.0k, Q4 2024 60.9k, Q1 2025 55.9k, Q2 2025 55.9k
80 GILEAD SCIENCES INC COM GILD GILD 51,416 $5.7m0.13% 0.13% ReducedShares held: Q3 2024 46.0k, Q4 2024 48.4k, Q1 2025 55.0k, Q2 2025 51.4k -3.6k -3,606 -6.5%
81 IQVIA HLDGS INC COM IQV IQV 33,700 $5.3m0.12% 0.12% ReducedShares held: Q3 2024 129.8k, Q4 2024 44.8k, Q1 2025 61.1k, Q2 2025 33.7k -27.4k -27,368 -44.8%
82 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 28,655 $4.9m0.11% 0.11% AddedShares held: Q3 2024 0, Q4 2024 2.5k, Q1 2025 1.9k, Q2 2025 28.7k +26.8k +26,755 1408.2%
83 BAXTER INTL INC COM BAX BAX 152,291 $4.6m0.10% 0.10% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 456.4k, Q2 2025 152.3k -304.2k -304,155 -66.6%
84 OMADA HEALTH INC COM OMDA OMDA 250,000 $4.6m0.10% 0.10% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 250.0k
85 BRIGHTSPRING HEALTH SVCS INC COM BTSG BTSG 191,706 $4.5m0.10% 0.10% ReducedShares held: Q3 2024 0, Q4 2024 174.2k, Q1 2025 241.7k, Q2 2025 191.7k -50.0k -50,043 -20.7%
86 10X GENOMICS INC CL A COM TXG TXG 326,751 $3.8m0.08% 0.08% AddedShares held: Q3 2024 281.9k, Q4 2024 270.7k, Q1 2025 231.0k, Q2 2025 326.8k +95.8k +95,754 41.5%
87 BIONTECH SE SPONSORED ADS BNTX BNTX 35,039 $3.7m0.08% 0.08% AddedShares held: Q3 2024 8.7k, Q4 2024 8.3k, Q1 2025 8.0k, Q2 2025 35.0k +27.1k +27,075 340.0%
88 CARDINAL HEALTH INC COM CAH CAH 20,012 $3.4m0.07% 0.07% ReducedShares held: Q3 2024 30.2k, Q4 2024 22.3k, Q1 2025 20.8k, Q2 2025 20.0k -764 -764 -3.7%
89 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 85,438 $3.0m0.07% 0.07% ReducedShares held: Q3 2024 169.1k, Q4 2024 167.3k, Q1 2025 91.2k, Q2 2025 85.4k -5.8k -5,753 -6.3%
90 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 38,400 $2.7m0.06% 0.06% ReducedShares held: Q3 2024 33.5k, Q4 2024 35.7k, Q1 2025 40.0k, Q2 2025 38.4k -1.6k -1,600 -4.0%
91 ILLUMINA INC COM ILMN ILMN 27,624 $2.6m0.06% 0.06% UnchangedShares held: Q3 2024 45.2k, Q4 2024 43.7k, Q1 2025 27.6k, Q2 2025 27.6k
92 CENCORA INC COM COR COR 7,970 $2.4m0.05% 0.05% ReducedShares held: Q3 2024 72.1k, Q4 2024 77.5k, Q1 2025 71.4k, Q2 2025 8.0k -63.4k -63,390 -88.8%
93 MERCK & CO INC COM MRK MRK 28,239 $2.2m0.05% 0.05% ReducedShares held: Q3 2024 42.2k, Q4 2024 264.2k, Q1 2025 231.4k, Q2 2025 28.2k -203.1k -203,132 -87.8%
94 KESTRA MED TECHNOLOGIES LTD SHS KMTS KMTS 133,761 $2.2m0.05% 0.05% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 133.8k, Q2 2025 133.8k
95 CVS HEALTH CORP COM CVS CVS 30,096 $2.1m0.05% 0.05% ReducedShares held: Q3 2024 22.1k, Q4 2024 21.8k, Q1 2025 31.8k, Q2 2025 30.1k -1.7k -1,659 -5.2%
96 SPDR S&P 500 ETF TR TR UNIT SPY SPY 3,100 $1.9m0.04% 0.04% ReducedShares held: Q3 2024 0, Q4 2024 5.7k, Q1 2025 5.7k, Q2 2025 3.1k -2.6k -2,560 -45.2%
97 BRISTOL-MYERS SQUIBB CO COM BMY BMY 37,177 $1.7m0.04% 0.04% AddedShares held: Q3 2024 36.8k, Q4 2024 38.1k, Q1 2025 25.6k, Q2 2025 37.2k +11.6k +11,611 45.4%
98 PFIZER INC COM PFE PFE 70,915 $1.7m0.04% 0.04% ReducedShares held: Q3 2024 141.1k, Q4 2024 141.6k, Q1 2025 120.7k, Q2 2025 70.9k -49.8k -49,831 -41.3%
99 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 15,927 $1.5m0.03% 0.03% ReducedShares held: Q3 2024 1.2m, Q4 2024 569.0k, Q1 2025 61.3k, Q2 2025 15.9k -45.3k -45,334 -74.0%
100 DOXIMITY INC CL A DOCS DOCS 23,816 $1.5m0.03% 0.03% UnchangedShares held: Q3 2024 29.1k, Q4 2024 27.9k, Q1 2025 23.8k, Q2 2025 23.8k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
BRUKER CORP BRKR BRKR 335,288 $14.0m335.3k shares
ESPERION THERAPEUTICS INC NE ESPR ESPR 9,694,064 $14.0m9.7m shares
TENET HEALTHCARE CORP THC THC 94,722 $12.7m94.7k shares
SAREPTA THERAPEUTICS INC SRPT SRPT 149,113 $9.5m149.1k shares
CASTLE BIOSCIENCES INC CSTL CSTL 301,103 $6.0m301.1k shares
EVOLENT HEALTH INC EVH EVH 614,337 $5.8m614.3k shares
ALTIMMUNE INC ALT ALT 1,056,793 $5.3m1.1m shares
BIO RAD LABS INC BIO BIO 21,476 $5.2m21.5k shares
ASTRANA HEALTH INC ASTH ASTH 163,155 $5.1m163.2k shares
DR REDDYS LABS LTD RDY RDY 91,916 $1.2m91.9k shares
SANOFI SNY SNY 16,000 $887.4k16.0k shares
ZAI LAB LTD ZLAB ZLAB 20,000 $722.8k20.0k shares
VAXCYTE INC PCVX PCVX 11,290 $426.3k11.3k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-05-15 VRDN 6.6%≈ $123.6m new 13G 2026-05-15
IMMUNOCORE HLDGS PLC IMCR · 13G · filed 2025-11-14 IMCR 5.6% new 13G 2025-11-14
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-08-14 JBIO 5.0%≈ $67.9m -1.8 pts 13G 2026-08-14